These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35916266)

  • 21. An optimized microplate-based method to evaluate complement-dependent hemolysis mediated by intravenous immunoglobulins (IVIG).
    Wang Y; Khalenkov A; Scott DE
    Biologicals; 2022 Jul; 78():1-9. PubMed ID: 35842374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis.
    Daw Z; Padmore R; Neurath D; Cober N; Tokessy M; Desjardins D; Olberg B; Tinmouth A; Giulivi A
    Transfusion; 2008 Aug; 48(8):1598-601. PubMed ID: 18466176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous immune globulin-related hemolysis: comparing two different methods for case assessment.
    Taylor E; Vu D; Legare C; Keene D
    Transfusion; 2015 Jul; 55 Suppl 2():S23-7. PubMed ID: 26174894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature.
    Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA
    Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications.
    Welsh KJ; Bai Y
    J Clin Apher; 2015 Dec; 30(6):371-4. PubMed ID: 26123478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Don't neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia.
    Ucar İ; Koyuncu MB; Solmaz AA; Ugurludogan AC; Mercan S; Kucuk M; Unal T; Mazman S; Atilla E
    Transfus Clin Biol; 2023 Feb; 30(1):11-15. PubMed ID: 36028153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of a monocyte monolayer assay in the assessment of intravenous immunoglobulin-associated hemolysis.
    Tong TN; Blacquiere M; Sakac D; Burke-Murphy E; Yi Q; Callum J; Cserti-Gazdewich C; Parmar N; Shehata N; Pavenski K; Lau W; Lin Y; Lieberman L; Branch DR; Pendergrast J
    Transfusion; 2020 Dec; 60(12):3010-3018. PubMed ID: 33091964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three or four doses of intravenous immunoglobulin G treatment for isoimmune hemolytic disease: A case series and literature review.
    Zheng Y; Almeyda-Alejo Y; Tumin D; Redpath NSJ; Guillen-Hernandez J
    J Neonatal Perinatal Med; 2024; 17(1):153-158. PubMed ID: 38143377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemolytic anemia associated with intravenous immunoglobulin.
    Wilson JR; Bhoopalam H; Fisher M
    Muscle Nerve; 1997 Sep; 20(9):1142-5. PubMed ID: 9270670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of inflammation in intravenous immune globulin-mediated hemolysis.
    Pendergrast J; Willie-Ramharack K; Sampson L; Laroche V; Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S65-73. PubMed ID: 26174900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specifications for anti-A and anti-B in intravenous immunoglobulin: history and rationale.
    Thorpe SJ
    Transfusion; 2015 Jul; 55 Suppl 2():S80-5. PubMed ID: 26174902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.
    Wallenhorst C; Patel A; Shebl A; Hubsch A; Simon TL; Martinez C
    Transfusion; 2020 Jul; 60(7):1381-1390. PubMed ID: 32488887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
    Markvardsen LH; Christiansen I; Harbo T; Jakobsen J
    Eur J Neurol; 2014; 21(1):147-52. PubMed ID: 24180709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion-Transmitted Injuries Surveillance System (Ontario).
    Batarfi K; Liu Y; Nixon J; Webert KE; John MS; Karunakaran M; Alhomsi N; Park JJ; Heddle NM
    Vox Sang; 2023 Sep; 118(9):753-762. PubMed ID: 37592865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.
    Figueras-Aloy J; Rodríguez-Miguélez JM; Iriondo-Sanz M; Salvia-Roiges MD; Botet-Mussons F; Carbonell-Estrany X
    Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of immunoglobulin treatment for hemolysis on the incidence of necrotizing enterocolitis - a meta-analysis.
    Yang Y; Pan JJ; Zhou XG; Zhou XY; Cheng R; Hu YH
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3902-3910. PubMed ID: 27735024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG).
    Coghill J; Comeau T; Shea T; Braddy L; Bandarenko N; Afenyi-Annan A; Harvey D
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):786-8. PubMed ID: 16785068
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin.
    Ergaz Z; Gross D; Bar-Oz B; Peleg O; Arad I
    Vox Sang; 1995; 69(2):95-9. PubMed ID: 8585207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.